524 related articles for article (PubMed ID: 31518344)
21. Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection.
Chen YC; Li CY; Tsai SJ; Chen YC
World J Gastroenterol; 2018 Feb; 24(8):917-928. PubMed ID: 29491685
[TBL] [Abstract][Full Text] [Related]
22. Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study.
Janjua NZ; Wong S; Abdia Y; Jeong D; Buller-Taylor T; Adu PA; Samji H; Wilton J; Pearce M; Butt ZA; Yu A; Binka M; Bartlett S; Alvarez M; Krajden M
J Hepatol; 2021 Nov; 75(5):1049-1057. PubMed ID: 34097994
[TBL] [Abstract][Full Text] [Related]
23. Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012.
Alavi M; Grebely J; Hajarizadeh B; Amin J; Larney S; Law MG; George J; Degenhardt L; Dore GJ
BMC Infect Dis; 2018 May; 18(1):215. PubMed ID: 29743015
[TBL] [Abstract][Full Text] [Related]
24. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
[TBL] [Abstract][Full Text] [Related]
25. Mediation effect of hepatitis B and C on mortality.
Huang YT; Freeman JR; Yang HI; Liu J; Lee MH; Chen CJ
Eur J Epidemiol; 2016 Jun; 31(6):625-33. PubMed ID: 26792787
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis.
Wang Z; Sheng YY; Dong QZ; Qin LX
World J Gastroenterol; 2016 Mar; 22(10):3038-51. PubMed ID: 26973400
[TBL] [Abstract][Full Text] [Related]
28. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
[TBL] [Abstract][Full Text] [Related]
29. Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.
Chang FM; Wang YP; Lang HC; Tsai CF; Hou MC; Lee FY; Lu CL
Hepatology; 2017 Sep; 66(3):896-907. PubMed ID: 28318053
[TBL] [Abstract][Full Text] [Related]
30. Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis.
Hoang JK; Yang HI; Le A; Nguyen NH; Lin D; Vu VD; Chaung K; Nguyen V; Trinh HN; Li J; Zhang JQ; Chen CJ; Nguyen MH
Medicine (Baltimore); 2016 Aug; 95(31):e4433. PubMed ID: 27495067
[TBL] [Abstract][Full Text] [Related]
31. Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B.
Lee TY; Hsu YC; Yu SH; Lin JT; Wu MS; Wu CY
Clin Gastroenterol Hepatol; 2018 Jun; 16(6):947-954.e4. PubMed ID: 28951229
[TBL] [Abstract][Full Text] [Related]
32. Hepatic decompensation in patients with HIV/Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) triple infection versus HIV/HCV coinfection and the effect of anti-HBV nucleos(t)ide therapy.
Lo Re V; Wang L; Devine S; Baser O; Olufade T
Clin Infect Dis; 2014 Oct; 59(7):1027-31. PubMed ID: 24944235
[TBL] [Abstract][Full Text] [Related]
33. Interferon-Based Treatment of Hepatitis C Virus Infection Reduces All-Cause Mortality in Patients With End-Stage Renal Disease: An 8-Year Nationwide Cohort Study in Taiwan.
Hsu YH; Hung PH; Muo CH; Tsai WC; Hsu CC; Kao CH
Medicine (Baltimore); 2015 Nov; 94(47):e2113. PubMed ID: 26632730
[TBL] [Abstract][Full Text] [Related]
34. Risk of diabetes in viral hepatitis B or C patients compared to that in noninfected individuals in Korea, 2002-2013: A population-based cohort study.
Choi HY; Kim Y; Cho H; Kim BH; Ki M
J Viral Hepat; 2018 Mar; 25(3):272-280. PubMed ID: 29080254
[TBL] [Abstract][Full Text] [Related]
35. Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: Data from a national US cohort.
Serper M; Forde KA; Kaplan DE
J Viral Hepat; 2018 Feb; 25(2):187-197. PubMed ID: 28845882
[TBL] [Abstract][Full Text] [Related]
36. Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection.
Lieveld FI; Smit C; Richter C; van Erpecum KJ; Spanier BWM; Gisolf EH; Vrolijk JM; Siersema PD; Hoepelman AIM; Reiss P; Arends JE
Liver Int; 2019 Mar; 39(3):470-483. PubMed ID: 30411848
[TBL] [Abstract][Full Text] [Related]
37. Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
Kovari H; Ledergerber B; Battegay M; Rauch A; Hirschel B; Foguena AK; Vernazza P; Bernasconi E; Mueller NJ; Weber R
Clin Infect Dis; 2010 Feb; 50(4):502-11. PubMed ID: 20085465
[TBL] [Abstract][Full Text] [Related]
38. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.
Liu CJ
J Gastroenterol Hepatol; 2014 Jan; 29(1):26-30. PubMed ID: 24199625
[TBL] [Abstract][Full Text] [Related]
39. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B.
Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861
[TBL] [Abstract][Full Text] [Related]
40. Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study.
Colussi G; Donnini D; Brizzi RF; Maier S; Valenti L; Catena C; Cavarape A; Sechi LA; Soardo G
World J Gastroenterol; 2019 Oct; 25(40):6094-6106. PubMed ID: 31686765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]